Cempra, Inc. (CEMP)

[Johnny_C]

I 100% agree that IV is more difficult to enroll and most likely more expensive. But the press release was a bit sketchy because these Bozo's made it sound like they did some great negotiating with the FDA. Moreover, the larger and quicker sales will come from a hospital setting where it is life and death. This is also more profitable. If they do get approval with oral they still are a second line antibiotic. The CT company also has little or no experience in rolling out a drug. Hopefully, if the trial goes well they Partner with big Pharma. As big as PFE is Eloquis is still growing sales 2 years later.

The call was about the worse I have ever been on. They have numbers, the BOD would have had to have reviewed numbers before approving this. Of course you would know what the cap structure is and what debt is.

Cemp is trading under NET cash right now, that is how badly they bungled call. The overseas partners seem top rate.

The simple math they use outs the new entity at around the $10.00 mark. Since $3. is cash, when you add in Japan and the patents one would hope this shakes out close to 10 but they are dumbas**s